
|Articles|July 1, 1998
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
- Volume 4
- Issue 7 Suppl
What are the Pharmacological Differences Between Angiotensin II Antagonists
Author(s)Thomas Unger, MD
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Gene Polymorphism Influences Response to Angiotensin Blockadeover 27 years ago
New Drug Class Offers Benefits in Heart Failureover 27 years ago
Exploring the Benefits Beyond Blood Pressure ControlNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Cardio-Oncology Collaboration Could Reduce Cardiovascular, Breast Cancer Risks: Eric H. Yang, MD
2
AI in Health Care Could Improve Accuracy, Efficiency, and Outcomes: Amrita Basu, PhD
3
Top 5 Trending FDA Approvals of 2025
4
Number of Medicare Beneficiaries With HIV Expected to Double in Next Decade
5







































